These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 11302599)
21. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage. Fabrizio F; Bunnapradist S; Martin P J Nephrol; 2002; 15(6):605-13. PubMed ID: 12495272 [TBL] [Abstract][Full Text] [Related]
22. Coimbra University Hospitals' bone and tissue bank: twenty-two years of experience. Judas F; Teixeira L; Proença A Transplant Proc; 2005; 37(6):2799-801. PubMed ID: 16182813 [TBL] [Abstract][Full Text] [Related]
23. Deceased tissue donor serology and molecular testing for HIV, hepatitis B and hepatitis C viruses: a lack of cadaveric validated tests. Victer TN; Dos Santos CS; Báo SN; Sampaio TL Cell Tissue Bank; 2016 Dec; 17(4):543-553. PubMed ID: 27329292 [TBL] [Abstract][Full Text] [Related]
25. The prevalence of positive hepatitis B, hepatitis C, and HIV serology in cornea donors prescreened by medical and social history in Ontario, Canada. Armstrong SA; Gangam N; Chipman ML; Rootman DS Cornea; 1997 Sep; 16(5):512-6. PubMed ID: 9294680 [TBL] [Abstract][Full Text] [Related]
26. Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study. Korelitz JJ; Williams AE; Busch MP; Zuck TF; Ownby HE; Matijas LJ; Wright DJ Transfusion; 1994 Oct; 34(10):870-6. PubMed ID: 7940658 [TBL] [Abstract][Full Text] [Related]
27. Organ donor screening using parallel nucleic acid testing allows assessment of transmission risk and assay results in real time. Baleriola C; Tu E; Johal H; Gillis J; Ison MG; Law M; Coghlan P; Rawlinson WD Transpl Infect Dis; 2012 Jun; 14(3):278-87. PubMed ID: 22519518 [TBL] [Abstract][Full Text] [Related]
28. Hemoconcentration prior to serology testing in hemodiluted cadaver bone and tissue donors. LeFor WM; Shires DL; McGonigle AF; Shires DL Clin Transplant; 1995 Aug; 9(4):297-300. PubMed ID: 7579736 [TBL] [Abstract][Full Text] [Related]
29. Skin donors and human skin allografts: evaluation of an 11-year practice and discard in a referral tissue bank. Gaucher S; Khaznadar Z; Gourevitch JC; Jarraya M Cell Tissue Bank; 2016 Mar; 17(1):11-9. PubMed ID: 26275343 [TBL] [Abstract][Full Text] [Related]
30. Syphilis serology in blood donors: a possible surrogate marker for human immunodeficiency virus risk. Ramsey G; Soltis F; Bowman R; McNamee J; Hahn LF; Dixon BW Vox Sang; 1991; 60(3):165-8. PubMed ID: 1862640 [TBL] [Abstract][Full Text] [Related]
31. Should antibody to hepatitis B core antigen be tested in routine screening of donor corneas for transplant? Mattern RM; Cavanagh HD Cornea; 1997 Mar; 16(2):138-45. PubMed ID: 9071525 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of cryopreserved donor skin viability: the experience of the regional tissue bank of Verona. Franchini M; Zanini D; Bosinelli A; Fiorini S; Rizzi S; D'Aloja C; Vassanelli A; Gandini G; Aprili G Blood Transfus; 2009 Apr; 7(2):100-5. PubMed ID: 19503630 [TBL] [Abstract][Full Text] [Related]
33. Impact of hepatitis B core antibody status on outcomes of cadaveric renal transplantation: analysis of United network of organ sharing database between 1994 and 1999. Fong TL; Bunnapradist S; Jordan SC; Cho YW Transplantation; 2002 Jan; 73(1):85-9. PubMed ID: 11792984 [TBL] [Abstract][Full Text] [Related]
34. Analyses of the effects of collection and processing time on the results of serology testing of cadaveric cornea donors. Bensoussan D; Jeulin H; Decot V; Agrinier N; Venard V Diagn Microbiol Infect Dis; 2010 Sep; 68(1):40-5. PubMed ID: 20727468 [TBL] [Abstract][Full Text] [Related]
35. Organ transplantation from "increased infectious risk donors": the experience of the Nord Italia Transplant program - A retrospective study. Grossi PA; Dalla Gasperina D; Lombardi D; Ricci A; Piccolo G; Nanni Costa A Transpl Int; 2018 Feb; 31(2):212-219. PubMed ID: 29057524 [TBL] [Abstract][Full Text] [Related]
36. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations. Wang J; Liu J; Huang Y; Wright DJ; Li J; Zhou Z; He W; Yang T; Yao F; Zhu X; Wen G; Bi X; Tiemuer MH; Wen X; Huang M; Cao R; Yun Z; Lü Y; Ma H; Guo N; Yu Q; Ness P; Shan H; Transfusion; 2013 Oct; 53(10 Pt 2):2489-97. PubMed ID: 23781978 [TBL] [Abstract][Full Text] [Related]
37. Processing efficacy in relation to microbial contamination of skin allografts from 723 donors. Pianigiani E; Ierardi F; Cuciti C; Brignali S; Oggioni M; Fimiani M Burns; 2010 May; 36(3):347-51. PubMed ID: 19616385 [TBL] [Abstract][Full Text] [Related]
38. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers. Cable R; Musavi F; Notari E; Zou S; Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796 [TBL] [Abstract][Full Text] [Related]
39. [Analysis of causes of death and etiological characteristics of skin tissue donors]. Ye ZQ; Xie WG; Lu XB; Chen X; Zhao CL; Ruan QF; Zhang W Zhonghua Shao Shang Za Zhi; 2020 Jun; 36(6):446-450. PubMed ID: 32594703 [No Abstract] [Full Text] [Related]
40. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR Recomm Rep; 1991 Apr; 40(RR-4):1-17. PubMed ID: 1850496 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]